IBDEI0KF ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9495,2)
 ;;=^5005587
 ;;^UTILITY(U,$J,358.3,9496,0)
 ;;=H35.021^^41^478^42
 ;;^UTILITY(U,$J,358.3,9496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9496,1,3,0)
 ;;=3^Exudative Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,9496,1,4,0)
 ;;=4^H35.021
 ;;^UTILITY(U,$J,358.3,9496,2)
 ;;=^5005586
 ;;^UTILITY(U,$J,358.3,9497,0)
 ;;=H35.373^^41^478^67
 ;;^UTILITY(U,$J,358.3,9497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9497,1,3,0)
 ;;=3^Puckering of Macula,Bilateral
 ;;^UTILITY(U,$J,358.3,9497,1,4,0)
 ;;=4^H35.373
 ;;^UTILITY(U,$J,358.3,9497,2)
 ;;=^5005664
 ;;^UTILITY(U,$J,358.3,9498,0)
 ;;=H35.31^^41^478^60
 ;;^UTILITY(U,$J,358.3,9498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9498,1,3,0)
 ;;=3^Nonexudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,9498,1,4,0)
 ;;=4^H35.31
 ;;^UTILITY(U,$J,358.3,9498,2)
 ;;=^5005647
 ;;^UTILITY(U,$J,358.3,9499,0)
 ;;=H31.422^^41^478^96
 ;;^UTILITY(U,$J,358.3,9499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9499,1,3,0)
 ;;=3^Serous Choroidal Detachment,Left Eye
 ;;^UTILITY(U,$J,358.3,9499,1,4,0)
 ;;=4^H31.422
 ;;^UTILITY(U,$J,358.3,9499,2)
 ;;=^5005484
 ;;^UTILITY(U,$J,358.3,9500,0)
 ;;=H31.421^^41^478^97
 ;;^UTILITY(U,$J,358.3,9500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9500,1,3,0)
 ;;=3^Serous Choroidal Detachment,Right Eye
 ;;^UTILITY(U,$J,358.3,9500,1,4,0)
 ;;=4^H31.421
 ;;^UTILITY(U,$J,358.3,9500,2)
 ;;=^5005483
 ;;^UTILITY(U,$J,358.3,9501,0)
 ;;=B58.01^^41^478^105
 ;;^UTILITY(U,$J,358.3,9501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9501,1,3,0)
 ;;=3^Toxoplasma Chorioretinitis
 ;;^UTILITY(U,$J,358.3,9501,1,4,0)
 ;;=4^B58.01
 ;;^UTILITY(U,$J,358.3,9501,2)
 ;;=^5000724
 ;;^UTILITY(U,$J,358.3,9502,0)
 ;;=H34.812^^41^478^10
 ;;^UTILITY(U,$J,358.3,9502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9502,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,9502,1,4,0)
 ;;=4^H34.812
 ;;^UTILITY(U,$J,358.3,9502,2)
 ;;=^5005569
 ;;^UTILITY(U,$J,358.3,9503,0)
 ;;=H34.823^^41^478^109
 ;;^UTILITY(U,$J,358.3,9503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9503,1,3,0)
 ;;=3^Venous Engorgement,Bilateral
 ;;^UTILITY(U,$J,358.3,9503,1,4,0)
 ;;=4^H34.823
 ;;^UTILITY(U,$J,358.3,9503,2)
 ;;=^5005574
 ;;^UTILITY(U,$J,358.3,9504,0)
 ;;=H34.822^^41^478^110
 ;;^UTILITY(U,$J,358.3,9504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9504,1,3,0)
 ;;=3^Venous Engorgement,Left Eye
 ;;^UTILITY(U,$J,358.3,9504,1,4,0)
 ;;=4^H34.822
 ;;^UTILITY(U,$J,358.3,9504,2)
 ;;=^5005573
 ;;^UTILITY(U,$J,358.3,9505,0)
 ;;=H34.821^^41^478^111
 ;;^UTILITY(U,$J,358.3,9505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9505,1,3,0)
 ;;=3^Venous Engorgement,Right Eye
 ;;^UTILITY(U,$J,358.3,9505,1,4,0)
 ;;=4^H34.821
 ;;^UTILITY(U,$J,358.3,9505,2)
 ;;=^5005572
 ;;^UTILITY(U,$J,358.3,9506,0)
 ;;=H43.813^^41^478^115
 ;;^UTILITY(U,$J,358.3,9506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9506,1,3,0)
 ;;=3^Vitreous Degeneration,Bilateral
 ;;^UTILITY(U,$J,358.3,9506,1,4,0)
 ;;=4^H43.813
 ;;^UTILITY(U,$J,358.3,9506,2)
 ;;=^5005955
 ;;^UTILITY(U,$J,358.3,9507,0)
 ;;=H43.812^^41^478^116
 ;;^UTILITY(U,$J,358.3,9507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9507,1,3,0)
 ;;=3^Vitreous Degeneration,Left Eye
 ;;^UTILITY(U,$J,358.3,9507,1,4,0)
 ;;=4^H43.812
 ;;^UTILITY(U,$J,358.3,9507,2)
 ;;=^5005954
 ;;^UTILITY(U,$J,358.3,9508,0)
 ;;=H43.811^^41^478^117
 ;;^UTILITY(U,$J,358.3,9508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9508,1,3,0)
 ;;=3^Vitreous Degeneration,Right Eye
 ;;^UTILITY(U,$J,358.3,9508,1,4,0)
 ;;=4^H43.811
 ;;^UTILITY(U,$J,358.3,9508,2)
 ;;=^5005953
